Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7676
Myomo
MYO
$62.2M
| $730K | ﹤0.01% |
+113,391
| New | +$552K |
|
7677
PUT
BGC Group
BGC
$5.31B
| $730K | ﹤0.01% |
80,600
-15,400
| -16% | -$148K |
|
7678
Sanara MedTech
SMTI
$312M
| $730K | ﹤0.01% |
21,984
+1,491
| +7% | +$50.6K |
|
7679
Southern Missouri Bancorp
SMBC
$841M
| $730K | ﹤0.01% |
+12,721
| New | +$781K |
|
7680
PUT
MillerKnoll
MLKN
$1.59B
| $730K | ﹤0.01% |
32,300
+19,200
| +147% | +$464K |
|
7681
Nomura Holdings
NMR
$28.7B
| $730K | ﹤0.01% |
126,017
-255,881
| -67% | -$1.45M |
|
|
AZUL
7682
PUT
DELISTED
Azul
AZUL
| $729K | ﹤0.01% |
436,600
+170,500
| +64% | +$444K |
|
7683
CALL
Amplify Energy
AMPY
$200M
| $729K | ﹤0.01% |
121,500
-24,900
| -17% | -$163K |
|
7684
Invesco S&P MidCap 400 Pure Value ETF
RFV
$341M
| $729K | ﹤0.01% |
6,010
+835
| +16% | +$103K |
|
7685
PUT
Community Health Systems
CYH
$416M
| $729K | ﹤0.01% |
243,800
+3,700
| +2% | +$15.5K |
|
|
ACB
7686
PUT
Aurora Cannabis
ACB
$228M
| $729K | ﹤0.01% |
171,500
+15,200
| +10% | +$74.6K |
|
|
VERV
7687
DELISTED
Verve Therapeutics
VERV
| $729K | ﹤0.01% |
129,202
-615,853
| -83% | -$3.47M |
|
7688
Vanguard Intermediate-Term Tax-Exempt Bond ETF
VTEI
$1.53B
| $729K | ﹤0.01% |
+7,330
| New | +$733K |
|
7689
Schwab Fundamental US Small Company Index ETF
FNDA
$9.27B
| $728K | ﹤0.01% |
24,515
+8,427
| +52% | +$257K |
|
7690
Vesta Real Estate
VTMX
$3.14B
| $728K | ﹤0.01% |
28,431
+11,816
| +71% | +$302K |
|
7691
OneWater Marine
ONEW
$191M
| $728K | ﹤0.01% |
+41,868
| New | +$895K |
|
7692
Frequency Electronics
FEIM
$824M
| $727K | ﹤0.01% |
+39,276
| New | +$552K |
|
|
FBRT
7693
Franklin BSP Realty Trust
FBRT
$667M
| $727K | ﹤0.01% |
+58,000
| New | +$750K |
|
7694
CALL
Invesco Taxable Municipal Bond ETF
BAB
$991M
| $727K | ﹤0.01% |
27,800
-56,100
| -67% | -$1.5M |
|
7695
PUT
Alignment Healthcare
ALHC
$2.79B
| $727K | ﹤0.01% |
+64,600
| New | +$755K |
|
7696
PUT
Direxion Daily Energy Bear 2X ETF
ERY
$35.7M
| $727K | ﹤0.01% |
28,800
+8,700
| +43% | +$198K |
|
7697
PUT
Phathom Pharmaceuticals
PHAT
$751M
| $726K | ﹤0.01% |
89,400
+77,000
| +621% | +$954K |
|
7698
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$295M
| $726K | ﹤0.01% |
15,057
-24,240
| -62% | -$1.19M |
|
7699
Braskem
BAK
$801M
| $726K | ﹤0.01% |
188,056
-145,990
| -44% | -$806K |
|
7700
USCB Financial Holdings
USCB
$416M
| $726K | ﹤0.01% |
40,894
+19,850
| +94% | +$347K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.